IPQ Analytics, LLC
@IPQAnalytics
Followers
16
Following
0
Media
1
Statuses
17
IPQ Analytics, LLC provides risk assessment solutions and decision analytics to constituents in life science and healthcare.
Media, PA
Joined November 2011
0
0
0
Improving study design and outcome - join our Webinar next Tuesday 9/25, email: pascal.soares@ipqanalytics.com.
0
0
0
The average drug developed by a major pharma company costs at least $4 billion, and it can be as much as $11 billion. http://t.co/ZLHPevE6.
0
0
0
Project objectives killing R&D productivity in the Pharma industry?, vote here: http://t.co/HjMsFATE.
0
0
0
There is still a major gap between what a drug does, or how it works, and what it’s approved for. Off-label use is not the answer.
0
0
0
Something to be fixed. - The results of publicly funded clinical trials have to get published. http://t.co/7IxjYvLC.
0
0
0
Risk in CTs is when survival rates when compared with the investigational drug shows rates FAVORING those receiving the placebo. C Infinity.
0
0
0
In-silico drug discovery progress; comp. method identifies which molecular mechanisms are altered by genetic mutations that lead to disease.
0
0
0
Michael Liebman from IPQ at PONTE EU project at the EU Open Day, Cambridge University Hospital, Cambridge, UK Jan 31 - http://t.co/rBHJyM17.
0
0
0
According to research the human brain doesn't judge the merits of an idea solely on logic, but also on how intrinsically true the idea feels.
0
0
0
Where are the new drugs? - Generics accounted for 78 percent of retail prescriptions in 2010, up from 63 percent in 2006 (source IMS).
0
0
0
The Pennsylvania’s trade office in Germany is bringing in a delegation of 23 companies and organizations from Germany to PA. We like this.
0
0
0
We will be presenting at Biotech Showcase in SFO, January 9–11, 2012. Come and join us. Details to follow.
1
0
0
We are presenting at the Medical Strategies Conferences January 2012, Cambridge University.
0
0
0